The need for new device therapies in HFrEF

Name: The need for new device therapies in HFrEF
Uploaded: 2022-06-21T10:39:16.000Z
Duration: 6 min 8 s

1,965 views

CVRx | Barostim

56 videos

Barostim™ Baroreflex Activation Therapy is a new option for patients with heart failure that utilizes the carotid baroreflex to target autonomic imbalance in the cardiovascular system.

Speakers

Jagmeet Singh

Speaker

Jagmeet Singh is a professor of medicine at Harvard Medical School, Massachusetts General... Jagmeet Singh is a professor of medicine at Harvard Medical School, Massachusetts General Hospital,Boston, MA, USA.

Join the conversation

to comment

The need for new device therapies in HFrEF

Speakers

Jagmeet Singh

Speaker

Join the conversation